StockData
Natera, Inc. logo

Natera, Inc. (NTRA) stock

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30123% above fair value
$273.40−16.52 (-5.70%)

Close on Nov 20, 2026Market cap $39.41BP/E –Yield –

Natera gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Natera's gross profit for the twelve months ending Jun 30, 2020 was $169.04M, up 66.0% year over year. For fiscal 2018 it was $99.57M, up 34.3% from the year before. The highest annual figure on record is $99.57M in fiscal 2018.

Annual gross profit

PeriodPeriod endValueChange
FY2018Dec 31, 2018$99.57M+34.3%
FY2017Dec 31, 2017$74.12M-5.0%
FY2016Dec 31, 2016$78.02M+0.7%
FY2015Dec 31, 2015$77.51M-4.2%
FY2014Dec 31, 2014$80.89M+352.0%
FY2013Dec 31, 2013$17.90M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2020Jun 30, 2020$43.74M+43.3%
Q1 FY2020Mar 31, 2020$52.49M+123.2%
Q4 FY2019Dec 31, 2019$38.78M+60.4%
Q3 FY2019Sep 30, 2019$34.03M+44.2%
Q2 FY2019Jun 30, 2019$30.53M+38.3%
Q1 FY2019Mar 31, 2019$23.52M+8.2%
Q4 FY2018Dec 31, 2018$24.18M+57.8%
Q3 FY2018Sep 30, 2018$23.60M+10.8%
Q2 FY2018Jun 30, 2018$22.07M+24.5%
Q1 FY2018Mar 31, 2018$21.75M+38.7%
Q4 FY2017Dec 31, 2017$15.33M+35.6%
Q3 FY2017Sep 30, 2017$21.30M+8.5%
Q2 FY2017Jun 30, 2017$17.72M–
Q1 FY2017Mar 31, 2017$15.68M–
Q4 FY2016Dec 31, 2016$11.30M–
Q3 FY2016Sep 30, 2016$19.63M–

More Natera figures

See a number that looks wrong?